Monday, March 14, 2011

Google Alert - marketing

News6 new results for marketing
 
How to Improve Odds of Success in Video Marketing: Follow the Money
Search Engine Watch
How did Next New Networks become successful in video marketing? And, more importantly, what lessons can you learn from their eight-figure success story? If you haven't seen them yet, check out YouTube's two most watched videos in 2010, ...
See all stories on this topic »
Microsoft says 'sorry' after Japan quake marketing gaffe
Register
Six hours later the company was forced to apologise for the gaffe, after followers of its Bing account on Twitter complained that Microsoft was taking advantage of the quake by marketing its search engine. Microsoft should be applauded for donating the ...
See all stories on this topic »
HOW TO: Optimize Your E-mail Marketing for Social Media Results
Mashable
Marketers plan to increase spending on e-mail and social media marketing more than any other tactics in 2011, according to a recent survey. As marketers find opportunities to build audiences, conversation and conversions with clever cross-promotion ...
See all stories on this topic »
Apache Names Gilbronson, Bright to Lead Oil and Gas Marketing Activities
PR Newswire (press release)
HOUSTON, March 14, 2011 /PRNewswire/ -- Apache Corporation (NYSE, Nasdaq: APA) today announced that Dave Gilbronson and Mark Bright will lead Apache's oil and gas marketing organization, which will be divided along geographic lines. ...
See all stories on this topic »
DemandTec Decisions™ Defines New Era of Sales and Marketing Planning for ...
PR Newswire (press release)
With the completed acquisition of M-Factor, DemandTec now provides the industry's only analytical decision making platform with marketing mix, trade promotion, and shopper marketing optimization capabilities. DemandTec Decisions™ further supports ...
See all stories on this topic »
AstraZeneca pays $68.5 million in Seroquel marketing case
McKnight's Long Term Care News
States had charged AstraZeneca with marketing the drug, which is approved to treat schizophrenia and bipolar disorder, for use on elderly patients with dementia, among others. In the lawsuit, states also claimed the company hid the nature of the drug's ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Remove this alert.
Create another alert.
Manage your alerts.

No comments:

Post a Comment